Filter
1682
Filtered Results: 1682
Text search:
drug-resistant
TB
Featured
Recommendations
175
New Publications
453
Language
Document type
No document type
1075
Studies & Reports
208
Guidelines
188
Manuals
59
Strategic & Response Plan
50
Situation Updates
42
Fact sheets
31
Training Material
19
Infographics
5
Brochures
2
Online Courses
2
Videos
1
Countries / Regions
India
92
Western and Central Europe
66
South Africa
56
Kenya
54
Eastern Europe
47
Ethiopia
36
Nepal
34
Tanzania
33
Zambia
28
Global
28
Nigeria
27
Uganda
25
Malawi
25
Myanmar / Burma
25
Namibia
23
Africa
21
Ghana
20
Liberia
19
Bangladesh
19
Rwanda
18
Ukraine
18
Sierra Leone
17
Latin America and the Carribbean
17
Asia
17
Cambodia
16
Lesotho
15
South–East Asia Region
13
Philippines
12
Colombia
12
Russia
11
Senegal
10
Mozambique
10
Zimbabwe
9
Indonesia
9
Botswana
9
Pakistan
8
Eswatini/ Swaziland
8
Germany
7
Argentina
7
Tajikistan
7
Congo, Democratic Republic of
6
Venezuela
6
Haiti
5
Peru
5
Cameroon
4
Thailand
4
Brazil
4
El Salvador
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Paraguay
4
Albania
4
Armenia
4
Burkina Faso
3
South Sudan
3
Syria
3
Sudan
3
Benin
3
Bolivia
3
Western Pacific Region
3
Laos
3
Timor Leste/ East Timor
3
Vietnam
3
Guinea
2
Morocco
2
USA
2
Jordan
2
Papua New Guinea
2
Ecuador
2
Madagascar
2
Sri Lanka
2
West and Central Africa
2
Middle East and North Africa
2
Bhutan
2
Romania
2
Moldova
2
Iran
2
Georgia
2
Uruguay
2
Saudi Arabia
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Gambia
1
Central African Republic
1
North Macedonia
1
Switzerland
1
Hungary
1
Honduras
1
Greece
1
Guatemala
1
Mexico
1
Nicaragua
1
Chile
1
Poland
1
North Korea
1
Bulgaria
1
Estonia
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
664
Clinical Guidelines
152
Public Health
50
Capacity Building
23
Women & Child Health
23
Key Resources
23
Pharmacy & Technologies
17
Toolboxes
TB
619
AMR
175
HIV
174
Pharmacy
41
Caregiver
23
Refugee
21
Ebola
19
COVID-19
19
Polio
17
NTDs
17
Conflict
15
Global Health Education
15
Mental Health
13
Rapid Response
12
Planetary Health
11
Health Financing Toolbox
10
NCDs
9
Natural Hazards
4
Disability
3
Specific Hazards
2
Social Ethics
2
Cholera
1
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional ...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on ... and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support countries in the evidence-informed introduction and scale-up of holistic people-centred services for TB, comorbidities and health-related risk factors, with the goal of comprehensively addressing TB and other co-existing health conditions. It should be used in conjunction with relevant WHO guidelines. The Framework is intended for use by people working in ministries of health, other relevant line-ministries, policymakers, international technical and funding organizations, researchers, nongovernmental and civil society organizations, as well as primary care workers, specialist health practitioners, and community health workers who support the response to TB and comorbidities in both the public and private sectors.
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in ... vaccine development and implementation, who include stakeholders involved in vaccine research, financing, regulation and policy-making, manufacturing, introduction and procurement. The goal is to accelerate development of effective vaccines against TB and their rapid introduction into countries.
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread ... resistance in HAT patients where the genetic mechanism has been established.
The current goal of elimination of HAT as a public health problem by 2020 may be undermined by the emergence and spread of resistance to current or new drugs.
Insights into potential resistance mechanisms for current and new drugs will facilitate predictions of the likelihood of resistance and will also facilitate rational approaches to minimizing, monitoring, and tackling the future emergence of resistance.
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with ... and HIV in the specific settings of the WHO European Region.
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strat...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An ...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is...
The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden
countries. T o illustrate the recent increase in TB incidence in the region, ...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Le...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficu...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a ...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional ... treatment adherence workers, who can provide training and guidance to their staff using the guidance in this manual;
3. TB clinicians, programme managers, policy makers and other leaders, to make them aware of the full range of interventions required by a person on TB treatment to complete his or her treatment and thus understand the gap that often exists in the support provided to patients;
4. people who, with enhanced capacity and support, can act as peer counsellors and supporters for people affected by TB. This can include family members who, in most contexts, play an important role in offering support to people with TB.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing ...
